# Plain Language Summary: STAND Against Emerging Opioids Act

This bill makes tianeptine a controlled substance under federal law. Tianeptine is a drug that's currently sold legally in the United States under brand names like "Za Za Red" and "Tianna," often marketed as a dietary supplement or nootropic (brain-boosting) product. The bill would classify it as a Schedule III controlled substance, which is the same category as some prescription painkillers and certain other drugs with moderate abuse potential. Once this happens, tianeptine would be illegal to manufacture, distribute, or possess without a prescription, just like other controlled medications.

The reason lawmakers are pushing this is that tianeptine has become increasingly popular as a recreational drug because it produces opioid-like effects—it can create a high and is potentially addictive. People have been buying it online and in convenience stores to get high or to manage opioid withdrawal symptoms, which has raised concerns among health officials and law enforcement. By scheduling it as a controlled substance, the government would be able to crack down on illegal sales and distribution, similar to how they regulate other drugs of abuse.

The practical impact is that anyone currently using tianeptine for non-medical purposes would be breaking federal law if this bill passes. People who have legitimate medical reasons to use it would need to get it through a prescription from a doctor. The law would take effect 90 days after being signed, giving businesses and consumers a three-month window to adjust. This is part of a broader effort to combat emerging drug threats that aren't yet covered by existing drug laws.